Skip to content

Tina-quant D-Dimer recallZ-0352-2024 · Roche Diagnostics Operations, Inc. · initiated Oct 3, 2023

Open, Classified

Is my device affected?

  1. Compare the model, catalog and lot or serial numbers on your device or its packaging with the code information below. A recall usually covers only specific models or lots.
  2. If yours is listed, follow the instructions from Roche Diagnostics Operations, Inc. or your healthcare provider. The company's action is summarized under what the company is doing.
  3. Do not stop using a prescribed or implanted device on your own — talk to your healthcare provider first.

Where to find your model and lot numbers · What recall classes and statuses mean

Why it was recalled

Elevated results were detected with Li-heparin plasma samples when compared to citrated plasma samples.

FDA root cause category: Under Investigation by firm

What the company is doing

An URGENT MEDICAL DEVICE CORRECTION notification letter dated 10/3/23 was sent to customers. Actions Required " Roche recommends using citrated plasma for D-Dimer quantification until further notice. " If your laboratory continues to use Li-heparin plasma for D-Dimer quantification, you are required to confirm all results between 0.5 g FEU/mL and 0.675 g FEU/mL with another D-Dimer method or with a citrated plasma sample. " If your laboratory continues to use Li-heparin plasma for D-Dimer quantification and chooses to confirm results with another method, you may request credit for that testing from Roche. Contact your Roche sales representative to request reimbursement. " Please complete all sections of the Recall Response Form (TP-01981) enclosed with this UMDC and fax it to 1-844-491-7776 or email it to [email protected]. " File this Urgent Medical Device Correction (UMDC) for future reference. Credit for Confirmatory Testing If your laboratory continues to use Li-heparin plasma for D-Dimer quantification and chooses to confirm results with another method, you may request credit for that testing from Roche. Contact your Roche sales representative to request reimbursement. Distributor Actions Required " Read the enclosed Customer UMDC TP-01986. " Within 14 days from receipt of this UMDC, distribute a copy of the enclosed Customer UMDC TP-01986 to all customers to whom you have shipped the Tina-quant D-Dimer assays listed above in the last 2 years. " Please complete all sections of the Distributor Recall Response Form (TP-01985) enclosed with this UMDC and fax it to 1-844-491-7776 or email it to [email protected]. " File this UMDC and the enclosed Customer UMDC for future reference. Questions Please contact the Roche Support Network Customer Support Center, 24 hours a day, seven days a week at 1-800-428-2336 if you have questions about the information contained in this UMDC.

Recall details

Recall number
Z-0352-2024
Status
Open, Classified
Initiated by the company
Oct 3, 2023
Posted by the FDA
Nov 20, 2023
Recalling firm
Roche Diagnostics Operations, Inc.
Quantity
5,263 kits
Product code
GHH
FDA submissions
K062203
Distribution
US Nationwide distribution.

Product description

Tina-quant D-Dimer Test System, Fibrinogen/Fibrin Degradation Products Assay, Material Numbers 03001245322 - (cobas c 311, 501 and 502; INTEGRA 400 plus), 08105618190 - (cobas c 303 and 503)

Code information (models, lots, serial numbers)

All Lots Affected. UDI: 04015630914593 - (cobas c 311, 501 and 502; INTEGRA 400 plus) UDI: 07613336133651 - (cobas c 303 and 503)

Devices named in this recall

2 devices in the FDA device registry whose identifier appears in the recall's code information.

Product lines

Sources and updates

How recalls are matched to devices · Editorial policy · Report an error on this page